SOPHiA GENETICS Announces Launch of DEEP-Lung-IV Multimodal

Study to leverage deep learning-enabled analysis of the aggregation of real-world multimodal data to validate predictive signatures associated with response to immunotherapy and prognosis of

Related Keywords

Boston , Massachusetts , United States , Switzerland , America , , Research Use , Twitter , North America , Philippe Menu , Chief Medical Officer , Data Driven Medicine , Research Use Only , Looking Statements , Sophia , Enetics , Nnounces , Launch , Jeep , Young , Multimodal , Linical , Study ,